In this case study, we present data from a program in which we leveraged our discovery and development engine to find functional and developable antibodies against a single-pass transmembrane protein with complex biological function. By amplifying diversity from the natural immune repertoire and integrating antibody assessment technologies, we show a streamlined approach to finding optimal antibody candidates.